MPLT vs MEI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MPLT · MapLight Therapeutics$6.93 ▲ 11.41%
MEI · Methode Electronics$10.76 ▲ 5.91%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MPLT -55.0%
- MEI +62.2%
Head to head
| Metric | MPLT | MEI |
|---|---|---|
| Price | $6.93 | $10.76 |
| Change today | ▲ 11.41% | ▲ 5.91% |
| Market cap | $385.14M | $383.54M |
| Return, 3 months | -43.1% | -34.3% |
| Return, year to date | -60.5% | +64.8% |
| Return, 1 year | -55.6% | +65.1% |
| P/E (TTM) | – | – |
| P/B | 1.1 | 0.6 |
| P/E percentile vs own 5y | 95th | 9th |
| Dividend yield | – | 1.86% |
| Revenue growth (YoY, latest qtr) | – | +10.4% |
| Net profit growth (YoY) | -101.7% | -10.7% |
| Gross margin | – | 19.8% |
| Operating margin | – | 0.3% |
| Net margin | – | -3.5% |
| Return on equity | -445.2% | -5.4% |
| Analyst target vs. price | +286.7% | +132.3% |
| Analyst buy share | 50% | 100% |
| RSI (14) | 35 | 36 |
| 30-day volatility | 71.8% | 117.4% |
| Max drawdown, 1 year | -84.4% | -47.5% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MPLT is the largest of the group by market value.
- MEI has returned the most over the past year.
- MPLT has been the calmest stock over the last 30 days.